Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
6.81%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 4.1Close
$ 4.04 - $ 16.8 52-Week Range
Ticker Information
Ticker
VRCACompany Name
VERRICA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQVERRICA PHARMACEUTICALS INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
VRCA - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 1M | 6.81% | $ 14.7M |
| 3/31/2025 | $ 1.14M | 15.84% | $ 7.18M |
| 12/31/2024 | $ 1.27M | 16.77% | $ 7.57M |
| 9/30/2024 | $ 1.23M | 13.39% | $ 9.21M |
| 6/30/2024 | $ 1.1M | 7.92% | $ 13.91M |
| 3/31/2024 | $ 974K | 10.93% | $ 8.91M |
| 12/31/2023 | $ 836K | 16.32% | $ 5.12M |
| 9/30/2023 | $ 820K | 25.59% | $ 3.2M |
| 6/30/2023 | $ 806K | 9.37% | $ 8.61M |
| 3/31/2023 | $ 762K | 8.82% | $ 8.64M |
Key Performance Insights, Last 5 Years
- VERRICA PHARMACEUTICALS INC's latest trailing twelve months (TTM) DepAmor % stands at 0%.
- Over the past 5 years, VERRICA PHARMACEUTICALS INC's average DepAmor % has been 21.5%.
- The median DepAmor % for VERRICA PHARMACEUTICALS INC during this period was 9.09%
- VERRICA PHARMACEUTICALS INC reached its highest DepAmor % over the past 5 years at 130.63%.
- The lowest DepAmor % recorded by VERRICA PHARMACEUTICALS INC in the same timeframe 1.8%
VERRICA PHARMACEUTICALS INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for VERRICA PHARMACEUTICALS INC is calculated as follows: DepAmor [ $ 254K ] / Revenues [ $ 0 ]
(=) DepAmor % [ 0% ] VRCA - Depreciation and Amortization Margin, Last 5 years
1.8%
Minimum
Mar 31, 2021
130.63%
Maximum
Mar 31, 2022
21.5%
Average
9.09%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.85% with a standard deviation of 5.12%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.31K |
|---|---|
| min | -6.41% |
| max | 22.52% |
| average | 5.85% |
| median | 4.22% |
| std | 5.12% |